- Report
- January 2026
- 188 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 180 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- March 2026
- 367 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- November 2025
- 300 Pages
Global
From €3591EUR$3,995USD£3,117GBP
- Report
- September 2025
- 142 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- September 2025
- 200 Pages
Global
From €2688EUR$2,990USD£2,333GBP
- Report
- January 2026
- 186 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- November 2025
- 181 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- March 2026
- 349 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- November 2024
- 171 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- February 2024
- 117 Pages
Global
From €4270EUR$4,750USD£3,706GBP
- Report
- April 2023
- 115 Pages
Global
From €4270EUR$4,750USD£3,706GBP

The Diagnostic Antibodies market is a subset of the Diagnostics industry, which focuses on the development and production of antibodies used to detect and diagnose diseases. Diagnostic antibodies are used to detect the presence of a specific antigen in a sample, such as a blood or tissue sample. These antibodies are used to diagnose a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Diagnostic antibodies are also used to monitor the progression of a disease or to measure the effectiveness of a treatment.
The Diagnostic Antibodies market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abcam, Bio-Rad, Merck, Thermo Fisher Scientific, and Roche. Show Less Read more